← Back to Search

Behavioral Intervention

ASSIST for Childhood Apraxia of Speech (ASSIST Trial)

Phase 1
Recruiting
Led By Edwin Maas, Ph.D.
Research Sponsored by Temple University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 4;0 and 9;11 (years;months) at enrollment, based on parent report.
Age between 4;0 and 9;11 (years;months) at enrollment, based on parent report
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week post treatment
Awards & highlights

ASSIST Trial Summary

This trial is testing a new treatment for childhood apraxia of speech, which is a disorder that impairs the ability to speak clearly. The treatment, called ASSIST, is given in three different doses to see what is most effective. The goal is to improve the child's speech so that they can be more intelligible and participate in communication more.

Who is the study for?
This trial is for English-speaking children aged between 4 and 9 years with Childhood Apraxia of Speech (CAS). They must have a speech sound disorder, be able to speak at least 50 words, show communicative intent, and have normal hearing. Children with significant oral impairments, unrelated health issues that could affect participation, or a primary diagnosis other than CAS are not eligible.Check my eligibility
What is being tested?
The ASSIST program is being tested in this study. It's an intensive speech therapy designed specifically for kids with CAS. The research looks into how effective the treatment is when given over different lengths of time (2 vs. 4 weeks) and using various types of speech targets like simple versus complex sounds or real words against nonwords.See study design
What are the potential side effects?
Since ASSIST is a type of speech therapy intervention rather than a medication, it does not have side effects in the traditional sense. However, participants may experience fatigue from intensive practice or frustration if progress feels slow.

ASSIST Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 4 and 9 years old, according to my parent.
Select...
I am between 4 and 9 years old, according to my parent.
Select...
My speech test scores indicate I have a speech sound disorder.

ASSIST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Speech Accuracy of Treated Items
Secondary outcome measures
FOCUS-34 Total Score
ICS Average Score
Speech Accuracy of Untreated Generalization Items
+1 more

ASSIST Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Massed ASSISTExperimental Treatment1 Intervention
Study 3
Group II: Distributed ASSISTExperimental Treatment1 Intervention
Study 3
Group III: ASSISTExperimental Treatment1 Intervention
Study 1 and 2
Group IV: Delayed ControlActive Control1 Intervention
Study 1 and 2
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ASSIST
2016
N/A
~20

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Temple UniversityLead Sponsor
297 Previous Clinical Trials
82,553 Total Patients Enrolled
Edwin Maas, Ph.D.Principal InvestigatorTemple University

Media Library

ASSIST (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03903120 — Phase 1
Childhood Apraxia of Speech Research Study Groups: ASSIST, Delayed Control, Massed ASSIST, Distributed ASSIST
Childhood Apraxia of Speech Clinical Trial 2023: ASSIST Highlights & Side Effects. Trial Name: NCT03903120 — Phase 1
ASSIST (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03903120 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research testing allow for elderly participants?

"The age limit for patients in this clinical trial is 9 years old or younger, with a minimum age of 4 years old."

Answered by AI

Has the ASSIST software been cleared by the FDA?

"Since this is only a Phase 1 trial, there is very limited data supporting the safety or efficacy of ASSIST. We have given it a score of 1."

Answered by AI

Who else is applying?

What state do they live in?
New Jersey
How old are they?
< 18
What site did they apply to?
Temple University
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. Temple University: < 48 hours
Average response time
  • < 2 Days
~70 spots leftby Apr 2025